Celsee Diagnostics
Founded Year
2010Stage
Acquired | AcquiredTotal Raised
$41.19MAbout Celsee Diagnostics
Celsee Diagnostics is a healthcare company engaged in single-cell analysis and delivers clinical-grade technology designed to support the life sciences and precision medicine. Based on a gentle, gravity-induced, micro-well isolation technique, the patented technology forms the foundation for a scalable and flexible single-cell analysis platform that makes more experiments feasible. On April 9th, 2020, Celsee Diagnostics was acquired by Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb). Terms of the transaction were not disclosed.
Missing: Celsee Diagnostics's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Celsee Diagnostics's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing Celsee Diagnostics
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Celsee Diagnostics is included in 3 Expert Collections, including Medical Devices.
Medical Devices
8,633 items
Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.
Omics
1,267 items
Companies involved in the capture, sequencing, and/or analysis of genomic, transcriptomic, proteomic, and/or metabolomic data
Health IT
7,901 items
Celsee Diagnostics Patents
Celsee Diagnostics has filed 35 patents.
The 3 most popular patent topics include:
- Biotechnology
- Cell biology
- Molecular biology
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
5/5/2020 | 2/14/2023 | Molecular biology, DNA sequencing, Biotechnology, Molecular biology techniques, Genomics | Grant |
Application Date | 5/5/2020 |
|---|---|
Grant Date | 2/14/2023 |
Title | |
Related Topics | Molecular biology, DNA sequencing, Biotechnology, Molecular biology techniques, Genomics |
Status | Grant |
Latest Celsee Diagnostics News
Apr 4, 2023
Privacy Overview This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful. Strictly Necessary Cookies Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings. If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again. Enable or Disable Cookies 3rd Party Cookies This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages. Keeping this cookie enabled helps us to improve our website. Enable or Disable Cookies
Celsee Diagnostics Frequently Asked Questions (FAQ)
When was Celsee Diagnostics founded?
Celsee Diagnostics was founded in 2010.
Where is Celsee Diagnostics's headquarters?
Celsee Diagnostics's headquarters is located at 100 Phoenix Drive, Ann Arbor.
What is Celsee Diagnostics's latest funding round?
Celsee Diagnostics's latest funding round is Acquired.
How much did Celsee Diagnostics raise?
Celsee Diagnostics raised a total of $41.19M.
Who are the investors of Celsee Diagnostics?
Investors of Celsee Diagnostics include Bio-Rad Laboratories and Accelerate Michigan Innovation Competition.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.